Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02765997
Recruitment Status : Withdrawn (IRB Disapproval)
First Posted : May 9, 2016
Last Update Posted : December 5, 2017
Information provided by (Responsible Party):
Masonic Cancer Center, University of Minnesota

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : June 2022